Navigation Links
Two New Studies Report Increased Survival Rates in Tamiflu(R)-Treated Patients with Avian Flu (H5N1) and Severe Seasonal Flu
Date:9/13/2009

SAN FRANCISCO, Sept. 13 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that two new observational studies concluded that influenza patients treated with Tamiflu(R) (oseltamivir phosphate) had significantly higher survival rates than untreated patients. The studies, examining nearly 1,000 people, analyzed outcomes for two different groups -adults and children diagnosed with the highly pathogenic A (H5N1) avian influenza and adults hospitalized with seasonal influenza. Results, which build on similar findings(i), were presented today at the 49th ICAAC annual meeting in San Francisco.(ii,iii)

"These retrospective studies support the potential benefits of antiviral treatment in severe cases of influenza," said Dominick Iacuzio, Ph.D., medical director at Roche, which manufactures Tamiflu. "While Tamiflu is approved and used in many countries to treat and prevent all types of A and B influenza, these 'real-world' studies contribute to the body of clinical evidence."

Study Summaries

First Results from an Avian Influenza Case Registry (Presentation V-533) -- Sunday, September 13, 2009, 9:00 a.m. - 9:30 a.m. PT, Marriott Salon 9.

The study examined outcomes data for 215 patients from 10 countries who were diagnosed with the virulent A (H5N1) avian influenza. The retrospective observational study found that untreated patients had a mortality rate of 88%, with 11 out of 89 (12%) untreated patients surviving, in contrast to survival of 45 out of 85 (53%) patients who received at least one dose of Tamiflu up to 8 days after symptom onset. Among a subset of patients who received Tamiflu within 2 days of symptom onset, 5 out of 7 patients (71%) survived.

The study was conducted by researchers from Avex Avian Influenza Expert Group and the London School of Hygiene and Tropical Medicine, in collaboration with R
'/>"/>

SOURCE Roche
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ISTA Pharmaceuticals Announces Preliminary Results of T-Pred Studies
2. Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations
3. Adamas Pharmaceuticals Signs CRADA With U.S. Navy to Conduct Preclinical Studies of Triple-Combination Antiviral Drug Therapy for Influenza A, Including the Novel H1N1 Pandemic Strain
4. Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss
5. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
6. PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies
7. Infant Formula Company Teams With the University of Virginia Pediatrics Department to Conduct Clinical Studies
8. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
9. School of Dentistry Studies Link Between Oral Health and Memory
10. Cancer Treatment Centers of America(R) Studies Treatment That Aims Chemotherapy Directly at Ovarian Cancer Cells
11. New Studies Presented at European Society of Anaesthesia Further Validate Masimo PVI(TM) for Noninvasive and Continuous Fluid Monitoring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... FLINT, Mich. , Dec. 24, 2014  Diplomat ... largest independent specialty pharmacy, is proud to announce ... and quality at Diplomat, will take office as the ... 2015. The formal induction ceremony will take place Feb. ... which will be held at the Renaissance Center in ...
(Date:12/24/2014)... , Dec. 23, 2014 PuraMed BioScience®, ... of over-the-counter (OTC) medicinal and healthcare products, announced it ... MigraPure® H, a hemp-based, advanced headache relief product, for ... in Colorado , Washington ... With the MigraPure H Advanced headache relief ...
(Date:12/24/2014)... -- ResMed (NYSE: RMD ) today announced its ... device manufacturer BMC Medical Co., Ltd. The ... below infringe ResMed,s patents, and entered an order prohibiting BMC ... the United States : , iVolve nasal ... nasal pillows mask , iVolve full face mask ...
Breaking Medicine Technology:Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2
... ISELIN, N.J. , April 2 Pharmos Corporation (Pink ... Phase 2b trial and the status of financing operations. Dextofisopam ... 4, 2009, Pharmos modified the size of the Dextofisopam Phase ... minimum 300 patient trial. The trial is now essentially fully ...
... J. Fox Foundation for Parkinson,s Research announced that ... total funding available under three Critical Challenges research ... the most difficult hurdles standing in the way ... opportunities focus research efforts on key priority areas ...
Cached Medicine Technology:Pharmos Issues Business Update on Dextofisopam Trial and Financing 2Michael J. Fox Foundation Commits up to $6.5 Million in Funding for Critical Challenges in Parkinson's Disease 2Michael J. Fox Foundation Commits up to $6.5 Million in Funding for Critical Challenges in Parkinson's Disease 3
(Date:12/26/2014)... December 26, 2014 India Network Foundation, ... in the USA, announced today a new version of ... in choosing the right plan for their visiting parents. ... out of the selection process when choosing an insurance ... group with only a few clicks. Many elderly Asian ...
(Date:12/26/2014)... DW-InductionHeating.com (DaWei Induction Heating Co.) is a comprehensive ... and marketing of a series of induction heating equipment. ... series of induction brazing equipments . , According ... brazing refers to the joining of two or ... The manager says that there are fundamental differences in ...
(Date:12/25/2014)... The microscopy market is estimated to ... $5,756.0 million by 2019. Optical microscopy is the ... microscopes product segment is expected to show the ... focus on nanotechnology, technological advancements, and increasing federal ... , Get Full Copy of Report @ ...
(Date:12/25/2014)... The click strand woven bamboo flooring ... Today, the business announces a click strand woven ... 30, 2015. , Click strand woven bamboo flooring ... a well-known brand in the bamboo industry. It ... reliable bamboo flooring supplier. , “We are happy ...
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 The ... to 2023” focuses on the current treatment landscape, unmet ... cancer market. TS-1 is an anti-cancer drug which is ... orally and is also used for treating gastric cancer ... and otastat potassium. The drug was first approved in ...
Breaking Medicine News(10 mins):Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 3Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3
... a,renegade internet radio broadcaster and production company promoter, but ... particularly those with,disabilities - not exactly what you,d expect ... with the Hard Rock Cafe at Station Square,Lawless and ... planned,Pittsburgh,s first annual Rock for Autism on June 11, ...
... In between clients in his,Northfield, Illinois office, Jack Cox ... his business -- people seeking online therapy., Cox ... to his,traditional practice, recently began offering online therapy through,Psychology.com., ... are hesitant to visit me, or,any other therapist, in ...
... Sports or Play, CARLSBAD, Calif., May 13 ... of custom-fitted arch supports and,natural sponge rubber cushions, announced ... supports designed specifically for children ages 6 and older.,Two ... now,currently available at participating Good Feet Stores nationwide., ...
... CLARA, Calif., FURSTENFELDBRUCK, Germany and YOKOHAMA CITY,Japan, ... real-time,compression technology company, Schleifring und Apparatebau GmbH, ... medical and defense markets,and Tokyo Electron Device ... boards, today announced an agreement for the ...
... of Health Affairs reports on the first randomized trial ... expect from chronic disease management programs that serve low-income ... Medicaid leaders struggling to meet the needs of individuals ... management efforts, even among relatively low-risk patients, may be ...
... ... Quality Act (CEQA)., LOS ANGELES, May 12 ... expansion of its,Holy Cross Medical Center even as Superior Court Judge ... significantly flawed.,The groundbreaking ceremony held today appears to be an attempt ...
Cached Medicine News:Health News:Rockin' Out for Autism in Pittsburgh 2Health News:Psychology.com Seeing Growing Acceptance of Online Therapy 2Health News:Good Feet Announces New Arch Support Product Line for Children Ages 6 and Older 2Health News:Samplify Systems Announces Availability of Compression for Computed Tomography; Integrated Slip-Ring Solution to be Jointly Developed with Schleifring und Apparatebau and Tokyo Electron Device Ltd. 2Health News:Samplify Systems Announces Availability of Compression for Computed Tomography; Integrated Slip-Ring Solution to be Jointly Developed with Schleifring und Apparatebau and Tokyo Electron Device Ltd. 3Health News:Samplify Systems Announces Availability of Compression for Computed Tomography; Integrated Slip-Ring Solution to be Jointly Developed with Schleifring und Apparatebau and Tokyo Electron Device Ltd. 4Health News:Chronic disease management: Does it improve health and save money? 2Health News:Providence Holy Cross Medical Center Ignores Community, Environmental Concerns With Planned Expansion of Mission Hills Facility 2
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: